HomeCompareKIERF vs MRK

KIERF vs MRK: Dividend Comparison 2026

KIERF yields 3.45% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $31.8K in total portfolio value
10 years
KIERF
KIERF
● Live price
3.45%
Share price
$2.75
Annual div
$0.09
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.0K
Annual income
$431.22
Full KIERF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KIERF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKIERFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KIERF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KIERF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KIERF
Annual income on $10K today (after 15% tax)
$293.53/yr
After 10yr DRIP, annual income (after tax)
$366.54/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $7,961.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KIERF + MRK for your $10,000?

KIERF: 50%MRK: 50%
100% MRK50/50100% KIERF
Portfolio after 10yr
$40.9K
Annual income
$5,114.68/yr
Blended yield
12.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KIERF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
3.2
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KIERF buys
0
MRK buys
0
No recent congressional trades found for KIERF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKIERFMRK
Forward yield3.45%2.76%
Annual dividend / share$0.09$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$25.0K$56.8K
Annual income after 10y$431.22$9,798.13
Total dividends collected$3.9K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: KIERF vs MRK ($10,000, DRIP)

YearKIERF PortfolioKIERF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,045$345.32$11,206$366.19$161.00MRK
2$12,175$356.47$12,650$502.35$475.00MRK
3$13,394$367.22$14,407$694.19$1.0KMRK
4$14,710$377.57$16,585$967.82$1.9KMRK
5$16,127$387.52$19,342$1,363.89$3.2KMRK
6$17,653$397.06$22,913$1,947.19$5.3KMRK
7$19,295$406.20$27,662$2,823.89$8.4KMRK
8$21,060$414.93$34,159$4,173.35$13.1KMRK
9$22,958$423.27$43,337$6,308.80$20.4KMRK
10$24,996$431.22$56,776$9,798.13$31.8KMRK

KIERF vs MRK: Complete Analysis 2026

KIERFStock

Kier Group plc primarily engages in the construction business in the United Kingdom and internationally. The company operates through three segments: Construction, Infrastructure Services, and Property. It constructs power stations, roads, bridges, railways, tunnels, and buildings for public and private sectors including schools, hospitals and prisons; and provides maintenance services for the UK road, rail, and utilities infrastructure, as well as reactive repairs. The company also offers maintenance and compliance services; housing maintenance; and facilities management services, such as cleaning, grounds maintenance, security, and pest control, as well as environmental services; and invests in and develops property schemes and sites. In addition, it provides design and business services, including project and programme management, architecture and landscape design, civil and structural engineering, building services engineering, building information modelling, cost management, strategic estates advice, building and condition surveys, ICT design and installation, business case development and feasibility, and advisory services. Kier Group plc was incorporated in 1992 and is based in Salford, the United Kingdom.

Full KIERF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KIERF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KIERF vs SCHDKIERF vs JEPIKIERF vs OKIERF vs KOKIERF vs MAINKIERF vs JNJKIERF vs ABBVKIERF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.